12 completed. 12 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 12 | Completed 12 |
Follow Schizophreniform Disorders: new trials by email Literature Review of Schizophreniform Disorders trials Research Report on Schizophreniform Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Young Adults With Violent Behavior During Early Psychosis (Aim 2) adapted behavioral intervention - Schizophrenia, Schizo Affective Disorder | Not applicable | Completed | Columbia University | 12 | 2024-03-19 | 2026-10-05 |
| Academic-Community EPINET (AC-EPINET) Coordinated Specialty Care (CSC) - Schizophrenia, Schizoaffective Disorder | Not applicable | Completed | Indiana University | 74 | 2022-03-16 | 2025-12-24 |
| Horyzons: Implementation in Clinical Practice Horyzons USA - Schizophrenia, Schizoaffective Disorder | Not applicable | Completed | University of North Carolina, Chapel Hill | 85 | 2021-01-19 | 2024-08-15 |
| Neuromodulation of Social Cognitive Circuitry in People With Schizophrenia Spectrum Disorders Repetitive Transcranial Magnetic Stimulation, Repetitive Transcranial Magnetic Stimulation (Intermittent Theta Burst Stimulation), Repetitive Transcranial Magnetic Stimulation (Sham) - Schizophrenia, Schizoaffective Disorder | Not applicable | Completed | Centre for Addiction and Mental Health | 70 | 2020-11-30 | 2023-10-17 |
| ED to EPI: Using SMS to Improve the Transition From the Emergency Department to Early Psychosis Intervention Active SMS Intervention, Sham SMS - First Episode Psychosis, Psychosis | Not applicable | Completed | Centre for Addiction and Mental Health | 186 | 2020-09-21 | 2026-03-18 |
| Safety and Efficacy of Virtual Reality Mindfulness in Patients With Psychosis Virtual Reality Mindfulness Treatment, Experience relaxing scenery and music - Schizophrenia Spectrum Disorders, Schizophrenia | Not applicable | Completed | Chonbuk National University Hospital | 67 | 2020-04-08 | 2023-04-10 |
| Early Psychosis Intervention - Spreading Evidence-based Treatment NAVIGATE, Treatment as Usual - First Episode Psychosis, Schizophrenia, Childhood | Not applicable | Completed | Centre for Addiction and Mental Health | 100 | 2020-01-03 | 2026-03-18 |
| Targeting Physical Health in Schizophrenia: Physical Activity Can Enhance Life Randomized Control Trial PACE-Life, Exercise Intervention - Schizophrenia, Schizoaffective Disorder | Not applicable | Completed | University of North Carolina, Chapel Hill | 50 | 2019-12-20 | 2022-09-22 |
| Minnesota Community-Based Cognitive Training in Early Psychosis Targeted Cognitive Training, General Cognitive Exercises, Coordinated Specialty Care for First Episode Psychosis - Schizophrenia, Psychosis | Not applicable | Completed | University of Minnesota | 45 | 2017-05-19 | 2025-01-23 |
| Targeting Stress Reactivity in Schizophrenia: Integrated Coping Awareness Therapy I-CAT, Treatment as Usual - Schizophreniform Disorders | Not applicable | Completed | University of North Carolina, Chapel Hill | 38 | 2016-10-03 | 2021-03-03 |
| Neural Inhibition as a Mechanism of Nicotine Dependence Among Persons With Schizophrenia Nicotine patch, placebo, smoking cessation group therapy - Smoking, Nicotine Dependence | Not applicable | Completed | Centre for Addiction and Mental Health | 120 | 2007-02-01 | 2009-03-18 |
| A Comparative Study of New Medications for Psychosis in Adolescents quetiapine, olanzapine, risperidone - Psychotic Disorders, Schizophrenia | Not applicable | Completed | University of Minnesota | 30 | 2002-08-01 | 2006-09-11 |
Psychotic Disorders (12) · Schizophrenia (11) · Affective Disorders, Psychotic (2) · Schizophrenia Spectrum and Other Psychotic Disorders (2) · Aggression (1) · Bipolar Disorder (1) · Mental Disorders (1) · Motor Activity (1) · Psychological Well-Being (1) · Psychoses, Substance-Induced (1) · Schizophrenia, Childhood (1) · Schizophrenia, Paranoid (1) · Smoking (1) · Tobacco Use Disorder (1)
Mental Disorders (11) · Schizophrenia Spectrum and Other Psychotic Disorders (10) · Behavior (4) · Chemically-Induced Disorders (2) · Substance-Related Disorders (2) · Aberrant Motor Behavior in Dementia (1) · Behavioral Symptoms (1) · Bipolar and Related Disorders (1) · Mood Disorders (1) · Neurodevelopmental Disorders (1) · Personal Satisfaction (1) · Poisoning (1) · Social Behavior (1)
Therapeutics (2) · Olanzapine (1) · Quetiapine Fumarate (1) · Risperidone (1) · Tobacco Use Cessation Devices (1) · Transcranial Magnetic Stimulation (1)
Centre for Addiction and Mental Health (4) · University of North Carolina, Chapel Hill (3) · University of Minnesota (2) · Chonbuk National University Hospital (1) · Columbia University (1) · Indiana University (1)
United States (8) · Canada (4) · South Korea (1)
David L Penn, PhD (2) · George Foussias, MD, PhD (2) · Alan Breier (1) · Albert HC Wong, MD, PhD (1) · Anil Malhotra, MD (1) · Aristotle N Voineskos, MD, PhD (1) · Aristotle Voineskos, MD (1) · Aristotle Voineskos, MD, PhD (1) · David Penn, PhD (1) · Diana Perkins, MD (1) · Diana Perkins, MD, MPH (1) · Janet Durbin, PhD, MSc (1) · Jeff Daskalakis, MD, PhD (1) · Jonathan Jensen, M.D. (1) · Nicole Kozloff, MD, SM (1)
PMID 32499262, PMID 33334839, PMID 37252256, PMID 40643782, PMID 42526755
K23MH126312 (1), R01MH120588 (1), R33MH100250 (1), R34MH111852 (1)